Re-Opening Exercise Science Laboratories and Testing During the Covid-19 Endemic Phase

Dengel, Donald R.; Evanoff, Nicholas G.

doi:10.1055/a-1283-6256

Cited by 4 publications

(3 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, SARS-CoV-2 infection should be ruled out by nasopharyngeal swab prior to exercise testing. 221 Single-patient use equipment should be preferred, including face masks and disposable parts such as mouth pieces, and nose clips. Filtration devices within mask/mouthpiece apparatus may be considered.…”

Section: Diagnosis Of Cardiovascular Conditions In Covid-19 Patientsmentioning

confidence: 99%

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

Baigent¹,

Windecker²,

Andreini³

et al. 2021

European Heart Journal

100

View full text Add to dashboard Cite

Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two-part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular disease (CVD) in association with COVID-19. Methods and results A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, reported here, focuses on the epidemiology, pathophysiology, and diagnosis of cardiovascular (CV) conditions that may be manifest in patients with COVID-19. The second part, which will follow in a later edition of the journal, addresses the topics of care pathways, treatment, and follow-up of CV conditions in patients with COVID-19. Conclusion This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.

show abstract

Section: Diagnosis Of Cardiovascular Conditions In Covid-19 Patientsmentioning

confidence: 99%

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

Baigent¹,

Windecker²,

Andreini³

et al. 2021

European Heart Journal

100

View full text Add to dashboard Cite

show abstract

“…For athletes under the age of 17 years, parental consent was obtained to participate in the study. For scans conducted during the COVID-19 pandemic, guidelines for safe practices were followed to ensure proper and safe participation (3).…”

Section: Methodsmentioning

confidence: 99%

No Changes in Body Composition in NCAA Division I Collegiate Football Players because of COVID-19 Restrictions

Czeck¹,

Roelofs²,

Evanoff³

et al. 2022

Journal of Strength and Conditioning Research

View full text Add to dashboard Cite

Czeck, MA, Roelofs, EJ, Evanoff, NG, and Dengel, DR. No Changes in body composition in NCAA Division I Collegiate Football Players due to COVID-19 restrictions. J Strength Cond Res 36(6): 1749-1752, 2022-The purpose of this study was to explore the impact of coronavirus disease 2019 (COVID-19) restrictions on body composition, assessed by dual x-ray absorptiometry (DXA), between the 2020 postseason (pre-COVID-19 restrictions) and the 2021 postseason (post-COVID-19 restrictions) in collegiate football players (n 5 50).In addition, a subset of athletes (n 5 23) was used to explore body composition variables across 4 postseason time points. Body composition variables assessed were total and regional body fat percent, total mass, lean mass, fat mass, bone mineral content, bone mineral density, and visceral adipose tissue mass. Paired t-tests were used to determine differences between the 2020 postseason and the 2021 postseason in body composition variables. Analysis of variance with Tukey HSD post hoc tests assessed significant differences in total and regional body composition across 4 years while adjusting for multiple comparisons. There were no significant differences (p . 0.05) between postseason 2020 and postseason 2021 for all measures of body composition. In a subset of athletes, body composition was analyzed over a 4-year period of time. There were no significant differences between all 4 time points for all measures of body composition. In conclusion, body composition variables in this study's subjects were not affected because of coronavirus disease 2019 restrictions or over 4 years of their collegiate football career.

show abstract

“…Furthermore, infection should be ruled out by performing a polymerase chain reaction (PCR) SARS-CoV-2 test within 48 to 72 h of CPET. [ 18 , 35 ] The use of viral filters is recommended for some CPET devices. However, it should be noted that test results may be affected.…”

mentioning

confidence: 99%

COVID-19, cardiac involvement and cardiac rehabilitation: Insights from a rehabilitation perspective - State of the Art

Tur¹,

Köseoğlu²,

Gökkaya³

et al. 2022

Turk J Phys Med Rehab

View full text Add to dashboard Cite

Since the beginning of the pandemic, many novel coronavirus disease 2019 (COVID-19) patients have experienced multisystem involvement or become critically ill and treated in intensive care units, and even died. Among these systemic effects, cardiac involvement may have very important consequences for the patient’s prognosis and later life. Patients with COVID-19 may develop cardiac complications such as heart failure, myocarditis, pericarditis, vasculitis, acute coronary syndrome, and cardiac arrhythmias or trigger an accompanying cardiac disease. The ratio of COVID-19 cardiac involvement ranges between 7 and 28% in hospitalized patients with worse outcomes, longer stay in the intensive care unit, and a higher risk of death. Furthermore, deconditioning due to immobility and muscle involvement can be seen in post-COVID-19 patients and significant physical, cognitive and psychosocial impairments may be observed in some cases. Considering that the definition of health is “a state of complete physical, mental and social well-being”, individuals with heart involvement due to COVID-19 should be rehabilitated by evaluating all these aspects of the disease effect. In the light of the rehabilitation perspective and given the increasing number of patients with cardiac manifestations of COVID-19, in this review, we discuss the rehabilitation principles in this group of patients.

show abstract

Re-Opening Exercise Science Laboratories and Testing During the Covid-19 Endemic Phase

Cited by 4 publications

References 26 publications

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

No Changes in Body Composition in NCAA Division I Collegiate Football Players because of COVID-19 Restrictions

COVID-19, cardiac involvement and cardiac rehabilitation: Insights from a rehabilitation perspective - State of the Art

Contact Info

Product

Resources

About